However, when we focused on probes that showed a nominally significant p-value in the DMP analysis of all samples, we confirmed our previous findings[16] that CD8+ T cells of MS patients display a higher degree of DNA methylation as compared to healthy controls (Fig 1). The gene discussed is CD8A; the disease is myeloid sarcoma.